RAD

Rite Aid Stock Is Still One of the Top Stocks to Avoid in 2020

With a heavy debt load and mounting competition, Rite Aid stock is looking like one to avoid as we begin 2020.

4 Top Stock Trades for Friday: TSLA, RAD, GIS, MED

General Mills, Tesla, Rite Aid and Medifast were our top stock trades from Thursday. Let's look at the charts going into Friday.

Rite Aid Earnings: RAD Stock Rockets 43% Higher on Better-Than-Expected Q3

Rite Aid (RAD) earnings for the U.S. pharmacy company's third quarter of fiscal 2020 have RAD stock flying high on Thursday.

7 of the Worst Retail Stocks That Refuse to Die

These once-profitable retail stocks have reached penny-stock status due to declining sales and financials that continue to deteriorate.

7 Unsteady Stocks Investors Should Consider Selling Before 2020

These stocks to sell will likely face pain in 2020 as these equities face worsening conditions and increasing financial and market pressure.

5 Lottery Stocks With Huge Upside — And a Real Chance of $0

These 5 stocks all have a real chance of winding up at zero — but if they can avoid that outcome, they could easily triple or more.

3 Big Stock Charts for Wednesday: Alphabet, AT&T, and Rite Aid

Wednesday's 3 big stock charts highlight recent market winners whose rallies may be petering out.

Even With New CEO, Debt-Laden Rite Aid Stock is Best Avoided for Near Term

RAD stock hasn't benefited when management gave up selling electronic cigarettes while taking on CBD products. That's not the turnaround strategy it needs.

The Comfort Zone Is Holding Rite Aid Stock Back

Believe it or not, Rite Aid has the opportunity to maximize its revenue profile. But getting there is a herculean task, leaving Rite Aid stock an avenue best left for speculators.

5 Beaten-Up Stocks to Buy That Could Be Saved By An Acquisition

Alphabet saved FIT stock with a big buyout, and these five stocks to buy could be next to be saved by an acquisition.

8 Penny Stocks That Have Fallen From Grace

These eight penny stocks have gone from winners to losers, and while some of them could go back to being winners, not all of them will.

5 Stocks to Sell Now, According to Wall Street

History says that Sell ratings from Wall Street are meaningful and predictive, so investors should shy away from these five stocks to sell.

The Roller Coaster Ride of Rite Aid Stock Is Much Ado About Nothing

RAD stock both rallied by 50% and dropped by 30% in September - and none of it had anything to do with the fundamentals of Rite Aid stock, which remain bad.

There’s No Management Turnaround That Will Boost Rite Aid Stock

Rite Aid stock – don’t wait for any management-led turnaround. This pharmacy retailer is laden with debt, cash flow losses and no clear turnaround plan.

Are Health Plans the Key to Rite Aid’s Savior?

Rather than trying desperately to find a buyer, Rite Aid will leverage their core strengths to bring value-add to their business. This is probably the best play available for Rite Aid stock.

With Any Turnaround Already Priced In, Avoid Rite Aid Stock

With this in mind, the stock is a hard pass. Investors likely can find more solid turnaround plays elsewhere. Given the volatility in the RAD stock prices, shares could shoot higher on speculation. But long term, Rite Aid stock is not a strong investment opportunity.

The Q2 Earnings Bump Is Not a Signal to Buy Rite Aid Stock

Rite Aid (NYSE:RAD) jumped more than 20% last week after exceeding second-quarter earnings guidance. The boost came at a good time. Rite Aid stock has…

7 Beaten-Up Value Stocks on the Rebound

Value is back in favor, and as it has come back in favor, these beaten-up value stocks have soared higher over the past month.

Rite Aid Earnings: RAD Stock Soars 5% on Q2 Beat

Rite Aid (RAD) earnings for the second quarter of fiscal 2020 have RAD stock taking off on Thursday on a strong EPS beat.